A recent study published in Fertility and Sterility has cast doubt on commonly used techniques during embryo transfer in assisted reproductive technologies. The research suggests that many standard practices lack robust scientific evidence supporting their effectiveness. This finding has sparked discussions among fertility specialists and patients seeking treatment. The study reviewed over 300 clinical trials conducted between 2000 and 2023. It found that while some methods, such as the timing of embryo transfer and the use of certain media for culturing embryos, are supported by moderate evidence, others remain unproven. For example, the routine use of hysterosalpingography before embryo transfer was found to have limited benefit and could potentially cause unnecessary discomfort. Similarly, the practice of using specific types of catheters for transferring embryos showed mixed results across different patient groups. The research team, led by Dr. Elena Mazzoni from the University of Milan, emphasized that the lack of high-quality randomized controlled trials means many procedures are based on tradition rather than proven outcomes. “We need more rigorous studies to determine which interventions truly improve pregnancy rates,” Mazzoni stated. The findings were presented at the European Society of Human Reproduction and Embryology conference earlier this month. In Italy, where the case of a woman receiving the wrong embryo during a fertility treatment recently came to light, the debate over standard practices has intensified. According to reports, a couple undergoing in vitro fertilization (IVF) was informed that they had received a non-viable embryo. The clinic initially denied the claim, but internal investigations later confirmed the error. The incident has raised concerns about quality control and transparency in fertility clinics. This case highlights broader issues within the field of assisted reproduction. While IVF has become increasingly common, the variability in protocols and the limited oversight of certain procedures mean that errors can occur. In response, several clinics in Italy have begun reviewing their internal processes and implementing stricter checks for embryo identification and handling. However, regulatory bodies such as the Italian National Institute of Health have yet to issue formal guidelines addressing these concerns. Patients who undergo fertility treatments often rely on the expertise of their doctors, but the growing body of evidence questioning traditional methods has left many confused. Some patients have started asking for alternative approaches, including less invasive techniques or participation in experimental studies. Others, however, remain skeptical of new recommendations, fearing that changes might reduce their chances of success. As the discussion continues, experts agree that further research is essential. A multidisciplinary task force has been formed to evaluate current practices and recommend standardized protocols. The group includes representatives from medical associations, ethics committees, and patient advocacy organizations. Their final report, expected by the end of the year, will aim to provide clear guidance for both clinicians and patients. For now, the focus remains on ensuring that all procedures are grounded in solid evidence. As one fertility specialist noted, “Until we have better data, we must be cautious about assuming that what has been done for years is always best.” The ongoing scrutiny of standard practices reflects a broader shift toward evidence-based care in reproductive medicine.
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.
Become a Supporter